ANSWER: The combination above cures a lot more than just COVID19.
Research Paper 1
“CHQ & HCQ successfully treated HIV, Q fever, Whipple’s disease, fungal infections, rheumatological (lupus erythematosus, antiphospholipid antibody syndrome, RA, Sjögren’s syndrome), & other immunological diseases.
Research Paper 2
“The expanding clinical applicability for these drugs includes rheumatological and cardiovascular disorders (CVD), chronic kidney disease (CKD), oncology, and a variety of nonmalarial infections. These clinical advancements are primarily related to pleiotropic pharmacological actions of these drugs, including immunomodulation, anti-inflammatory properties, and capabilities of inducing autophagy and apoptosis at a cellular level”
Research Paper 3
“Reduction in cardiovascular risk when treated with HCQ known for decades”
“Antithrombotic effects of HCQ reduction of platelet aggregation & inhibition of the release of alpha granule”
“Reduction of type two diabetes in patients treated with HCQ for other conditions” “Effect of HCQ on the glucose is related to changes in the intra-endosomal pH”
“Improvement of insulin sensitivity after six weeks of treatment with HCQ”
“Reports also reveal the effectiveness of HCQ in different diseases from the present rheumatic conditions, such as improved insulin sensitivity, ability to reduce thromboembolic events, reduction of lipid levels and treatment of infection by HIV”
Research Paper 4
“Scientific evidence also supports the use of CQ and HCQ in the treatment of cancer. Overall, preclinical studies support CQ and HCQ use in anti-cancer therapy”
Research Paper 5 (Patent)
“Use of hydroxychloroquine for the manufacture of a medicament for the treatment of graft-versus-host disease after bone marrow transplant.”
“Use of hydroxychloroquine for the manufacture of a medicament for suppressing alloreactivity arising from reaction of donor T lymphocytes against recipient cells.”